Background: Due to public stigma or self-stigma and shame, many adolescents with mental illness (MI) struggle with the decision whether to disclose their MI to others. Both disclosure and nondisclosure are associated with risks and benefits. Honest, Open, Proud (HOP) is a peer-led group program that supports participants with disclosure decisions in order to reduce stigma's impact. Previously, HOP had only been evaluated among adults with MI. Methods: This two-arm pilot randomized controlled trial included 98 adolescents with MI. Participants were randomly assigned to HOP and treatment as usual (TAU) or to TAU alone. Outcomes were assessed pre (T0/baseline), post (T1/after the HOP program), and at 3-week follow-up (T2/6 weeks after T0). Primary endpoints were stigma stress at T1 and quality of life at T2. Secondary outcomes included self-stigma, disclosure-related distress, empowerment, help-seeking intentions, recovery, and depressive symptoms. The trial is registered on ClinicalTrials (NCT02751229; http://www.clinicaltrials.gov). Results: Compared to TAU, adolescents in the HOP program showed significantly reduced stigma stress at T1 (d = .92, p < .001) and increased quality of life at T2 (d = .60, p = .004). In a longitudinal mediation model, the latter effect was fully mediated by stigma stress reduction at T1. HOP further showed significant positive effects on self-stigma, disclosure-related distress, secrecy, help-seeking intentions, attitudes to disclosure, recovery, and depressive symptoms. Effects at T1 remained stable or improved further at follow-up. In a limited economic evaluation HOP was cost-efficient in relation to gains in quality of life. Conclusions: As HOP is a compact three-session program and showed positive effects on stigma and disclosure variables as well as on symptoms and quality of life, it could help to reduce stigma's negative impact among adolescents with MI.
Introduction
Adolescents with mental illness (MI) often experience stigma and discrimination which can have a severe impact on long-term clinical, social, and vocational functioning (Kaushik, Kostaki, & Kyriakopoulos, 2016; Patel, Flisher, Hetrick, & McGorry, 2007) . Unlike other stigmatized characteristics, MI is often invisible. Therefore, many adolescents with MI struggle with the decision whether to disclose their condition to others. Disclosure may lead to labeling and discrimination, on the other hand it can offer opportunities for social support, facilitate help-seeking, increase authenticity, and decrease the stress associated with secrecy (Pachankis, 2007) . Given the consequences and irreversibility of disclosure, this can be a challenging decision and individuals may weigh the pros and cons differently. Honest, Open, Proud (HOP) is a peer-led group program that supports participants with MI in their disclosure decisions. HOP has so far only been evaluated in two RCTs among adults with MI (Corrigan et al., 2015; R€ usch, Abbruzzese, et al., 2014) , and both showed positive effects on stigma-related stress.
The concept of stigma stress is based on stresscoping models of stigma (Lazarus & Folkman, 1984) . It occurs when stigmatized individuals feel that stigma-related harm exceeds their coping resources (R€ usch et al., 2009) . If, on the other hand, people feel confident to cope with stigma, their level of stigma stress will be low. As disclosure decisions as well as stigma itself can be stressful and HOP supports participants in these domains, stigma stress is a plausible proximal outcome of HOP as evidenced by the above-mentioned RCTs. Noninterventional studies among adolescents and adults with MI showed consistent negative associations of stigma stress with quality of life and other aspects of well-being (R€ usch, M€ uller, Heekeren et al., 2014; R€ usch, M€ uller, Lay et al., 2014) . We, therefore, expected that stigma stress reductions would lead to improved quality of life over time as a distal outcome.
We conducted this pilot RCT to examine HOP's efficacy to reduce the impact of mental illness stigma on adolescents with MI and investigated the economic impact of the program in relation to mental health service use and quality of life outcomes. As two primary outcomes, compared to the control group we expected HOP to reduce short-term stigma stress after the 3-week program (T1); and to improve midterm quality of life after the 3-week follow-up period (T2). As secondary outcomes, we expected improvements in other stigma-and disclosure-related and clinical outcomes after the intervention and at followup.
Methods

Trial design and participants
In this two-arm 1:1-RCT, participants were randomly assigned to HOP, combined with treatment as usual (TAU), or to a control group that received only TAU. Participants were recruited from three Departments of Child and Adolescent Psychiatry (Ulm, Augsburg, Ravensburg-Weissenau) in southern Germany between May 2016 and February 2017. All departments had inpatient wards, day clinics, and outpatient clinics. As the recruitment of participants from the three outpatient clinics was not sufficient, an independent child and adolescent psychiatry outpatient practice in Ulm was added as a recruitment site. This practice treats adolescents comparable in illness severity and sociodemographic variables to other outpatient settings and mainly with attention deficit, conduct, anxiety or affective disorders. About one in four has a history of psychiatric inpatient treatment and access does not depend on the type of health insurance.
Inclusion criteria for all participants were: at least one selfreported current axis-I or axis-II disorder according to ICD-10 (WHO, 2010) in response to a list of major diagnostic categories; age 13-18; ability to provide written informed consent; fluent German language skills; and at least a moderate level of self-reported disclosure-related distress (≥4 for 'In general, how distressed or worried are you in terms of secrecy or disclosure of your mental illness to others?', rated from 1/not at all to 7/ very much). Exclusion criteria were intellectual disability; organic disorder; or diagnosis of only a substance-or alcohol-related disorder, without nonsubstance-related current psychiatric comorbidity, since disclosure of these disorders is not a topic specifically discussed in the HOP program. The trial was approved by the ethics committees of Ulm University and of the regional college of physicians. Parents or legal guardians as well as adolescents provided written informed consent after being fully informed about study procedures. Before including the first participants, the trial was registered on ClinicalTrials (NCT02751229; www.clinicaltrials.gov).
Sample size
Prior to this study, there were neither data on HOP's efficacy among adolescents nor data on HOP in inpatient settings. Furthermore, the HOP version for adolescents differs from the program for adults that was evaluated in previous RCTs. Based on a power of 80% to detect an effect on at least one endpoint, alphas of .025, and two primary endpoints with an expected correlation of r = À.3 (unpublished data), 100 participants were sufficient to detect medium effect sizes of d = .5 on stigma stress, similar to effects on stigma stress in a previous adult HOP RCT (R€ usch, Abbruzzese et al., 2014) , and d = .4 on quality of life.
Randomization
After completing the baseline assessment (T0), participants were randomly assigned to the intervention (HOP+TAU) or the control group (TAU alone) by block randomization separately for each study center. Randomization lists and closed envelopes were generated by the Institute of Epidemiology and Medical Biometry, University of Ulm, Germany. Blinding of participants was not feasible, and research staff were not blinded as outcomes were assessed by self-report. To reduce the risk of contamination between trial arms, HOP participants were asked not to share HOP materials with control group participants.
HOP Intervention
Honest, Open, Proud's goal is to support participants with the decision whether to disclose their MI in different settings. HOP was developed by Corrigan and colleagues based on a previous book (Corrigan & Lundin, 2001 As disclosure decisions depend on the setting and are very individual, HOP discusses levels of disclosure, settings of disclosure and how to choose persons to disclose to. It is not HOP's aim to push participants toward disclosure, but to empower them to make their own decision. HOP is a peer-led group program that covers five themes; (a) Beliefs: Starting with stories of adolescents in the workbook, participants explore attitudes about having a MI and ways to challenge self-stigmatizing beliefs; (b) Pros and Cons of Disclosure: Participants discuss short-term and long-term risks and benefits of (non)disclosure in different settings, levels of disclosure and disclosure via social media; (c) The right person: Participants learn how to find people that are good to disclose to and how to test them out before a potential disclosure, anticipating responses of others to one's disclosure; (d) Telling one's story: After reading first-person accounts in the workbook, participants practice how to tell their story, if they decide to do so, and how to identify peers who could support them; and (e) the role of solidarity and peer support, a summary of lessons learnt during the program and next steps. Lessons are structured by vignettes, first-person accounts, worksheets, tables, and role plays.
Honest, Open, Proud was conducted in three 2-hr sessions during a 3-week period. In previous HOP RCTs among adults with MI, two peers with lived experience of MI facilitated the groups. Due to the adolescent participants and the predominantly inpatient setting in this study, groups were facilitated by a young adult peer with lived experience of MI and a young mental health professional. Before recruitment onset, peer and professional group facilitators attended a HOP training conducted by NR and NM. Prior to the RCT, all facilitators ran at least one HOP practice group. Manual fidelity in the practice groups was >80%.
Fidelity
In order to check manual fidelity, a checklist covering the HOP workbook content was adapted from a previously used HOP fidelity scale (R€ usch, Abbruzzese et al., 2014) . One research assistant was present in every session and completed the fidelity checklist. Fidelity was high with 87%-98% for lesson one, 86%-97% for lesson two, and 79%-85% for lesson three. Mean fidelity across sessions and sites was 89%.
Measures
Outcomes were measured at three timepoints: baseline (Pre/ T0); immediately following the intervention, or 3 weeks after baseline for TAU-only participants (Post/T1); and 6 weeks after baseline (Follow-up/T2). We assessed two primary endpoints as defined a priori in the study protocol: Stigma stress reduction as proximal outcome at T1, and quality of life as distal outcome at T2. Stigma stress was assessed by the 8-item Stigma Stress Scale (R€ usch et al., 2009) . Four items measured the primary appraisal of stigma as harmful (alphas in our study .90/.93/.92 for T0/T1/T2) and four items the secondary appraisal of perceived resources to cope with stigma-related harm (alphas .70/.77/.89). All items were rated from 1 to 7, higher mean scores indicating more harm or more coping resources. A stigma stress score was computed by subtracting perceived resources from perceived harm, with higher difference scores (range À6 to +6) indicating more stigma stress. Health-related quality of life was measured with the KIDSC-REEN-10 index (Ravens-Sieberer et al., 2010) , with higher sum scores (range 10-50) indicating better quality of life (alphas .80/.85/.79).
Secondary outcomes included empowerment as measured by the 9-item Self-Esteem and the 4-item Optimism subscales of the Empowerment Scale (Rogers, Chamberlin, Ellison, & Crean, 1997) , with higher mean scores from 1 to 4 indicating stronger empowerment (alphas .91/.93/.91 and .56/.73/.77). Disclosure-related distress was examined by the above-mentioned screening item (R€ usch, Abbruzzese et al., 2014) . Two items assessed attitudes toward disclosure in one's personal or educational/professional environment, respectively ('In general, how comfortable would you feel talking to a friend or family member [item 1; '. . . to a teacher or employer . . .' in item 2] about your mental health, for example, telling them you have a mental health diagnosis and how it affects you?', from 1/not at all to 7/ very much). Hopelessness was examined with the 4-item brief version of Beck's Hopelessness Scale (Yip & Cheung, 2006) , with higher sum scores from 4 to 24 equaling more hopelessness (alphas .85/.81/.78). Self-stigma was assessed by two measures. First, the 10-item Internalized Stigma of Mental Illness Inventory-Short Form (ISMI; Boyd, Otilingam, & Deforge, 2014 ) is a broad measure that includes experienced discrimination and social withdrawal, with higher mean scores between 1 and 4 indicating more self-stigma (alphas .80/.76/.80). Second, the 5-item self-concurrence/apply subscale of the Self-Stigma of Mental Illness Scale-Short Form (SSMIS; Corrigan et al., 2012) assessed whether respondents applied negative stereotypes to themselves (alphas .70/.75/.81), higher sum scores from 5 to 45 equaling more self-stigma.
Participants reported intentions to seek help for mental health problems from different sources in the General Help Seeking Questionnaire (Wilson, Deane, Ciarrochi, & Rickwood, 2005) , from 1/extremely unlikely to 7/extremely likely. Based on a factor analysis of help-seeking intentions in an unrelated study (Waldmann et al., in preparation), we averaged intentions to seek help from family/friends (items 1-4) and from professionals (items 5, 7, 10). Recovery was examined by the 4-item Self-Identified Stage of Recovery Scale (Andresen, Caputi, & Oades, 2010) , higher sum scores from 4 to 24 indicating better recovery (alphas .74/.75/.73). Secrecy and social withdrawal were assessed using Link's Stigma Coping Orientation Scales (Link, Mirotznik, & Cullen, 1991) , with higher mean scores from 1 to 6 equaling more secrecy or withdrawal (alphas for five secrecy items .64/.72/.81; for seven social withdrawal items .74/.77/.74). Depressive symptoms were assessed using the 15-item German version of the Center for Epidemiologic Studies Depression Scale (Meyer & Hautzinger, 2001) 
Statistical analyses
Baseline characteristics of dropouts (n = 22) versus completers (n = 76) after 6 weeks were compared using t-tests or chisquare tests. We analyzed intervention effects first by intention-to-treat (ITT) analysis and a linear mixed model for repeated measures (MMRM; Ashbeck & Bell, 2016; Davis, 2014) ; and second by available case analysis using ANCOVAs. With two primary endpoints, we corrected the significance level for both to p < .025. All other analyses were exploratory with p < .05.
Our MMRM analysis used a restricted maximum likelihood (REML)-based repeated-measures approach. The analyses included the fixed, categorical effects of group, time point of measurement, and group-by-time point interaction as well as the fixed covariates of baseline score and center. An unstructured (co)variance structure shared across treatment groups was used to model the within-patient errors. The KenwardRoger approximation was used to estimate denominator degrees of freedom and adjust standard errors. Analyses were implemented with SAS PROC MIXED. Effect size d was calculated by dividing MMRM estimated group differences by the pooled standard deviation at baseline for each outcome.
For ANCOVAs we used all available data which is more conservative than a per-protocol analysis because participants who had been randomized to HOP but had not participated in all sessions were included (Figure 1 ). Intervention effects were tested using group as between-and time as within-subject factors; the baseline value of the respective outcome and center/site were used as covariates. Effect size estimates are provided as partial g², with g² of .10 or .25 indicating medium or large effect sizes (Vacha-Haase & Thompson, 2004) .
The hypothesized longitudinal mediation model of intervention effects on the two primary endpoints was tested using structural equation modeling within R version 3.3.3 (lavaan library; Figure 2 ). Changes in stigma stress from Pre/T0 to Post/T1 (T0-T1, difference scores >0 indicating decreased stigma stress) as well as changes in quality of life from T0 to T2 (T2-T0, differences >0 indicating increased quality of life) were calculated. Missing data were accounted for by Full Information Maximum Likelihood estimation, and bootstrapping ensured robust standard errors (bootstrap replications = 1,000).
To contextualize HOP outcomes in relation to program costs, we performed a limited threshold analysis, first to estimate the value of mental health service use which would need to be reduced for HOP to be economically efficient from a healthcare perspective and second to contextualize the quality of life outcomes. We estimated Quality Adjusted Life Years (QALYs) by mapping the KIDSCREEN-10 responses onto CHU9D utility scores using the algorithm recommended by Chen, Stevens, Rowen, and Ratcliffe (2014).
Results
Recruitment, assessment, and baseline characteristics
In total, we contacted 160 participants of whom 98 were included and randomized. With a low refusal rate, adolescents were mainly excluded due to low disclosure-related distress or lack of parental consent ( Figure 1) . Recruitment ended when the approximate planned sample size was reached. There were no significant group differences between the HOP and control groups at baseline (Table 1 ; all p-values >.35). All participants completed questionnaires at baseline (T0), 84 (86%) completed the postassessment (T1), and 76 participants (78%) the follow-up assessment (T2). Baseline characteristics of the 22 participants lost to follow-up did not differ significantly from the 76 completers (Table S1 ). Recruitment from the outpatient practice proved more difficult than expected, as many potential outpatient participants did not report sufficient disclosure-related distress. Altogether, we included 85 participants from inpatient settings (44 in the HOP, 41 in the control condition), seven from hospital day clinics, and six from the independent outpatient practice. No adverse events occurred among HOP or TAU participants.
Primary outcomes
In the MMRM analysis, we found significant HOP effects with a large effect size on the proximal primary endpoint of stigma stress after 3 weeks/T1 (Table 2) . Stigma stress continued to decrease among HOP participants at follow-up. With respect to our distal primary endpoint, we found a significant positive HOP effect on quality of life at followup/T2 with a medium effect size. Results were very similar in the ANCOVAs (Table S2) .
Secondary outcomes
In terms of secondary outcomes (Table 2) , we found significant and positive HOP effects on self-stigma both at T1 (at a trend level for the ISMI scale) and at T2, with effect sizes increasing from small to medium during follow-up. There were small, marginally significant short-term effects on empowerment in terms of self-esteem and optimism at T1 that lost significance at T2. Disclosure-related distress and secrecy were significantly reduced among HOP participants, with medium effect sizes at T1 and large effect sizes at T2. Social withdrawal decreased in the HOP group at T1. Intentions to seek help in one's private environment or from healthcare professionals increased significantly in the HOP group at T1 and remained significantly increased at T2 for professional help. HOP significantly reduced hopelessness at T2 in the available-case ANCOVA (Table S2) and at a trend level in MMRM (Table 2) . Attitudes toward disclosure among family/friends and in school or employment settings improved significantly among HOP group participants at T1 and T2. There was a small-to-medium effect on recovery at T2 among HOP participants. Finally, HOP had a large effect on depressive symptoms at T2.
Mediation analysis of intervention and both primary endpoints
In the path model estimated by structural equation modeling, the positive association between the HOP program and increased quality of life at followup (T2) was fully mediated by decreased stigma stress after the intervention (T1; Figure 2 ). Due to estimating a saturated model (df = 0), model fit could not be interpreted.
Limited economic evaluation
Costs for delivering HOP were estimated and included training peers and professionals, time for peers and professionals to deliver HOP, costs for printing training and HOP materials and venue hire. If we are very conservative and include the cost of training facilitators in addition to delivering HOP, program costs are estimated to be €154 per participant (€70 per participant if excluding training and set up costs). Although representative data on costs of mental health service use for young people do not exist in Germany, we know from data in Britain that average annual costs associated with mental health service use for young people aged 5-15 are €1,697 when inflated to 2016 levels (Snell et al., 2013) . Given that health service utilization and spending 
Participants' views
Peer group facilitators were seen as inspiring role models. Participants liked to learn about other participants' disclosure decisions and to hear their stories. They thought HOP improved their knowledge about disclosure and valued the clear structure of the workbook and its realistic scenarios. Participants liked the hands-on strategies how to talk about their MI and how to seek out persons to disclose to. Some felt relieved when talking about their MI in the safe group space. Participants highlighted the group interaction which was characterized by openness, trust, and respect. Some felt the first module was too theoretical and demanding, others found it hard to concentrate or thought some material was too detailed.
Discussion
Our findings support the feasibility, efficacy, and cost-effectiveness of HOP for adolescents. While the rhythms of hospital wards offered a challenge, including the early discharge of some participants, dropout rates remained moderate. Our hypothesis that HOP would improve stigma stress, as a proximal outcome after the intervention, and that this would lead to improved quality of life at follow-up was supported. HOP also led to significant improvements across a broad range of outcomes, including selfstigma, disclosure variables, help-seeking intentions and depressive symptoms. We also observed weaker positive effects on recovery and empowerment. This is promising and suggests that HOP can improve clinical and social outcomes when added to standard care. The three-session HOP program could be a useful, cost-efficient, and practical intervention as it is brief and can be delivered in a variety of settings.
This study has some implications for research and practice. Future studies should examine HOP's feasibility and efficacy in different settings as well as HOP's effect on actual disclosure decisions and the effects of these decisions on participants over time. As there are other interventions to reduce selfstigma, including narrative, psychoeducational, and acceptance-based approaches (Tsang et al., 2016) , future work should compare their efficacy among young people. Our findings suggest stronger HOP effects in this age group compared to previous RCTs among adults (Corrigan et al., 2015; R€ usch, Abbruzzese et al., 2014) . Several explanations are possible and could be examined in future research: Young people may be more open to discuss and change their views on disclosure; they might be more optimistic to deal successfully with stigma; and they may have a larger social network than adults with a long history of MI and thus have better opportunities to test, practice, and evaluate disclosure-related choices. Therefore, interventions to reduce stigma's impact may be particularly worthwhile in the early course of the illness (Gronholm, Thornicroft, Laurens, & Evans-Lacko, 2017) . This is in line with a public health perspective that underlines the negative consequences of stigma for adolescent mental health (Kaushik et al., 2016) and the scarcity of appropriate interventions for this target group (Patel et al., 2007) .
Limitations
Participants in our study were mainly recruited from inpatient settings and from only one independent outpatient practice which limits generalizability and conclusions about HOP in outpatient settings. Only a minority of approximately one in four outpatients appeared to be significantly distressed by disclosure decisions. Future HOP studies could examine its efficacy for that group and might consider a lower disclosure distress threshold. The 3-week follow-up period was brief and long-term effects remain unclear. Likewise the efficacy of a booster session to maintain shortand mid-term effects should be examined in future studies. We cannot rule out contamination between trial arms. Research staff were not blinded to group allocation. Although we collected data on intervention costs, the economic analysis is limited as we did not have cost data beyond intervention delivery. Future research should measure the impact of HOP on health service use, as reduced symptoms could lead to reduced service use while increased helpseeking intentions could lead to increased service use. Reduced stigma stress and increased helpseeking from friends/peers and family may also impact social relationships and educational performance; costs associated with these outcomes could also be considered in future studies in addition to the potential for HOP to increase participants' confidence in seeking future employment or other opportunities associated with potential economic impact.
Conclusions
If our findings are corroborated by future research, HOP can support adolescents with MI in their disclosure decisions and help them cope with stigma and discrimination. HOP has the potential to improve clinical outcomes as well as the recovery and well-being of adolescents.
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